Prevalence and Costs of Eosinophilic Esophagitis in the United States
Clinical Gastroenterology and Hepatology · 2025-02 · 23 (2) · 272-280.e8
DOI: 10.1016/j.cgh.2024.09.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025-02. Verfasst von Hannah L Thel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Health Care Costs. Die Arbeit wurde bisher 107-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH.
Abstract (Originalsprache)
BACKGROUND & AIMS: Eosinophilic esophagitis (EoE) has been continually increasing in prevalence, but current estimates are lacking. We aimed to determine updated estimates of the prevalence and medical costs associated with EoE in the United States (U.S.). METHODS: We used two large administrative databases, MarketScan and Medicare, and International Classification of Disease codes to calculate annual prevalence of EoE, as well as age- and sex-stratified estimates, standardized to the U.S. POPULATION: Health care utilization, including medications and endoscopic procedures, was quantified, and annual EoE-associated costs were estimated. RESULTS: We identified 20,435 EoE cases in MarketScan in 2022 and 1913 EoE cases in Medicare in 2017. This translated to prevalences of 163.08 cases/100,000 and 64.83 cases/ 100,000 in MarketScan and Medicare, respectively. There was a 5-fold increase in prevalence in both databases since 2009. In MarketScan, prevalence was higher among males (204.45/100,000 vs 122.06/100,000 among females); for both sexes, peak prevalence was from 40 to 44 years of age. Standardized to the U.S. population, the prevalence of EoE was 142.5/100,000, extrapolating to 472,380 cases. Total EoE-associated health care costs were estimated to be $1.32 billion in 2024 dollars after accounting for inflation. CONCLUSIONS: The prevalence of EoE continues to increase, with a rate of 1 in 617 in 2022 in those
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
- Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
- Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina; Department of Epidemiol…
- Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina; Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology,…
Förderung
- NIDDK NIH HHS
- NIH
Zitieren
APA
Thel, H. L., Anderson, C., Xue, A. Z., Jensen, E. T., & Dellon, E. S. (2025). Prevalence and Costs of Eosinophilic Esophagitis in the United States. Clinical Gastroenterology and Hepatology, 23(2), 272-280.e8. https://doi.org/10.1016/j.cgh.2024.09.031
Vancouver
Thel HL, Anderson C, Xue AZ, Jensen ET, Dellon ES. Prevalence and Costs of Eosinophilic Esophagitis in the United States. Clinical Gastroenterology and Hepatology. 2025;23(2):272-280.e8. doi:10.1016/j.cgh.2024.09.031
BibTeX
@article{Thel2025,
author = {Thel, Hannah L and Anderson, Chelsea and Xue, Angela Z and Jensen, Elisabeth T and Dellon, Evan S},
title = {Prevalence and Costs of Eosinophilic Esophagitis in the United States},
journal = {Clinical Gastroenterology and Hepatology},
year = {2025},
volume = {23},
number = {2},
pages = {272--280.e8},
doi = {10.1016/j.cgh.2024.09.031}
}
EUVIMED